Narrowing the policy gap: lessons from years 2 and 3 of the British Columbia influenza prevention policy

Influenza can be potentially fatal to vulnerable populations, particularly those in the hospital. Canada's National Advisory Committee on Immunization recommends that health-care workers (HCW) be immunized against influenza partly to avoid infecting high-risk populations. However, influenza imm...

Full description

Saved in:
Bibliographic Details
Main Authors: Antonia M. Di Castri (Author), Donna M. Halperin (Author), Charmaine M. McPherson (Author), Alexandra Nunn (Author), Haley Farrar-Muir (Author), Jeffrey C. Kwong (Author), Bonnie Henry (Author)
Format: Book
Published: Taylor & Francis Group, 2020-06-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_717e9ad44eb5489f8b51c405f0365f21
042 |a dc 
100 1 0 |a Antonia M. Di Castri  |e author 
700 1 0 |a Donna M. Halperin  |e author 
700 1 0 |a Charmaine M. McPherson  |e author 
700 1 0 |a Alexandra Nunn  |e author 
700 1 0 |a Haley Farrar-Muir  |e author 
700 1 0 |a Jeffrey C. Kwong  |e author 
700 1 0 |a Bonnie Henry  |e author 
245 0 0 |a Narrowing the policy gap: lessons from years 2 and 3 of the British Columbia influenza prevention policy 
260 |b Taylor & Francis Group,   |c 2020-06-01T00:00:00Z. 
500 |a 2164-5515 
500 |a 2164-554X 
500 |a 10.1080/21645515.2019.1692561 
520 |a Influenza can be potentially fatal to vulnerable populations, particularly those in the hospital. Canada's National Advisory Committee on Immunization recommends that health-care workers (HCW) be immunized against influenza partly to avoid infecting high-risk populations. However, influenza immunization rates among HCW remain suboptimal. In 2012, health authorities across British Columbia (B.C.) implemented a province-wide influenza prevention policy requiring HCW to either be immunized or wear a mask when in patient-care areas during the influenza season. This paper describes the second of two studies focused on what was learned from years 2 and 3 of the policy. A case study approach was used to examine this policy implementation event. Qualitative data were collected through key documents and key informant interviews with members of leadership teams responsible for policy implementation. Framework analysis and Prior's approach were used to analyze data from interviews and documents, respectively. Policy implementation varied by geographic region and gaps persist in immunization tracking and discipline for noncompliance. Debate regarding the scientific evidence used to support the policy fuels resistance from particular groups. Despite these challenges, findings suggest that the policy has been habituated, largely due to consistent policy objectives. This study emphasizes the importance of ongoing inter-professional and cross-sectoral program evaluation. While adherence may be routine for many, implementation processes must continue to respond to contextual issues to narrow the gap in policy implementation and to continue to engage stakeholders to ensure compliance. 
546 |a EN 
690 |a british columbia 
690 |a health personnel 
690 |a influenza vaccines 
690 |a immunization 
690 |a vaccination 
690 |a public health 
690 |a policy 
690 |a Immunologic diseases. Allergy 
690 |a RC581-607 
690 |a Therapeutics. Pharmacology 
690 |a RM1-950 
655 7 |a article  |2 local 
786 0 |n Human Vaccines & Immunotherapeutics, Vol 16, Iss 6, Pp 1354-1363 (2020) 
787 0 |n http://dx.doi.org/10.1080/21645515.2019.1692561 
787 0 |n https://doaj.org/toc/2164-5515 
787 0 |n https://doaj.org/toc/2164-554X 
856 4 1 |u https://doaj.org/article/717e9ad44eb5489f8b51c405f0365f21  |z Connect to this object online.